Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yissum Research Development Company of the Hebrew University of Jerusalem Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10818
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university’s faculty, staff, researchers, and students. Its products include exelon, doxil, cherry tomatoes and long shelf-life tomatoes, granagard, osmoter x6 facial serum, hybrid peppers, hygia nutrients, artichoke, cationorm, agcite, vuze, melon, periochip, ikervis, explora, superior ceramic ink, uv-pearl, seer, and bioresorbable adhesion barrier. YRDC transfers the technologies in various fields including computer science, medicine and pharmaceuticals, nanotechnology, water and environmental technologies, agriculture and nutrition, homeland security, and others. The company supports business partners in identifying the researcher to conduct the research and tailor the partnerships to the requirements of the business partner and the technologies. YRDC is headquartered in Jerusalem, Israel.

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Atox Bio Raises USD30 Million in Financing 14
Avraham Pharma Raises up to USD4.5 Million Financing 16
Avraham Pharma Raises USD4.5 Million in Venture Financing 17
Avraham Pharma Raises US$6 Million In Venture Financing 19
Integra Holdings Raises US$7 Million In First Round Financing 20
Partnerships 21
Phytecs Enters into Agreement with Yissum Research Development 21
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 22
Accurexa Enters into Agreement with Yissum Research Development 23
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 24
Licensing Agreements 25
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25
Spherium Biomed Enters into Option Agreement with Yissum 26
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 27
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 28
Immune Pharma Enters into Licensing Agreement with Yissum 29
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 31
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 32
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 33
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 34
Acquisition 36
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 36
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Key Competitors 37
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Key Employees 38
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Atox Bio Raises USD30 Million in Financing 14
Avraham Pharma Raises up to USD4.5 Million Financing 16
Avraham Pharma Raises USD4.5 Million in Venture Financing 17
Avraham Pharma Raises US$6 Million In Venture Financing 19
Integra Holdings Raises US$7 Million In First Round Financing 20
Phytecs Enters into Agreement with Yissum Research Development 21
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 22
Accurexa Enters into Agreement with Yissum Research Development 23
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 24
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25
Spherium Biomed Enters into Option Agreement with Yissum 26
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 27
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 28
Immune Pharma Enters into Licensing Agreement with Yissum 29
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 31
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 32
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 33
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 34
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 36
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Competitors 37
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Employees 38
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Subsidiaries 39

List of Figures
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SeaSpine Holdings Corporation (SPNE):企業の財務・戦略的SWOT分析
    SeaSpine Holdings Corporation (SPNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Capitol Federal Financial Inc:企業の戦略・SWOT・財務分析
    Capitol Federal Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Capitol Federal Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Indra Sistemas SA (IDR):企業の財務・戦略的SWOT分析
    Indra Sistemas SA (IDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Commercial International Bank (Egypt) SAE:企業の戦略・SWOT・財務情報
    Commercial International Bank (Egypt) SAE - Strategy, SWOT and Corporate Finance Report Summary Commercial International Bank (Egypt) SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Societe Generale S.A.:企業のM&A・事業提携・投資動向
    Societe Generale S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Societe Generale S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Conn’S, Inc.
    Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors a …
  • Carrefour SA:戦略・SWOT・企業財務分析
    Carrefour SA - Strategy, SWOT and Corporate Finance Report Summary Carrefour SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Northfork Electric Cooperative, Inc.:発電所・企業SWOT分析
    Northfork Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • TRACON Pharmaceuticals Inc (TCON):製薬・医療:M&Aディール及び事業提携情報
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product …
  • TBEA Xinjiang Sunoasis Co Ltd:電力:M&Aディール及び事業提携情報
    Summary TBEA Xinjiang Sunoasis Co Ltd (TBEA) is a renewable energy company that manufactures and markets solar energy products. The company offers products such as photovoltaic power generation systems, monocrystalline silicon wafers, polycrystalline silicon films, inverter control system, monocryst …
  • Zeus Co., Ltd. (079370):企業の財務・戦略的SWOT分析
    Zeus Co., Ltd. (079370) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tecan Group Ltd (TECN):医療機器:M&Aディール及び事業提携情報
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • KACO new energy GmbH:企業の戦略的SWOT分析
    KACO new energy GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Fomento de Construcciones y Contratas SA (FCC):企業の財務・戦略的SWOT分析
    Fomento de Construcciones y Contratas SA (FCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Cheetah Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Cheetah Medical Inc (Cheetah Medical) is a provider of non-invasive hemodynamic monitoring technologies. The company’s products comprise CHEETAH NICOM prewired sensors and Starling SV systems. It also offers Starling SV system accessories such as monitors and sensors, replacement parts, pole …
  • AZTherapies Inc-製薬・医療分野:企業M&A・提携分析
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company, which focuses on the discovery, development and commercialization of medicines for the treatment of Alzheimer’s disease and other neuroinflammatory and neurodegenerative diseases. Its product pipeline includes the le …
  • Firstsource Solutions Ltd (FSL):企業の財務・戦略的SWOT分析
    Firstsource Solutions Ltd (FSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Northwest Territories Power Corporation:企業の戦略的SWOT分析
    Northwest Territories Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆